Cargando…
Enhancement of solubility in Escherichia coli and purification of an aminotransferase from Sphingopyxis sp. MTA144 for deamination of hydrolyzed fumonisin B(1)
BACKGROUND: Fumonisin B(1 )is a cancerogenic mycotoxin produced by Fusarium verticillioides and other fungi. Sphingopyxis sp. MTA144 can degrade fumonisin B(1), and a key enzyme in the catabolic pathway is an aminotransferase which removes the C2-amino group from hydrolyzed fumonisin B(1). In order...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933618/ https://www.ncbi.nlm.nih.gov/pubmed/20718948 http://dx.doi.org/10.1186/1475-2859-9-62 |
_version_ | 1782186160359997440 |
---|---|
author | Hartinger, Doris Heinl, Stefan Schwartz, Heidi Elisabeth Grabherr, Reingard Schatzmayr, Gerd Haltrich, Dietmar Moll, Wulf-Dieter |
author_facet | Hartinger, Doris Heinl, Stefan Schwartz, Heidi Elisabeth Grabherr, Reingard Schatzmayr, Gerd Haltrich, Dietmar Moll, Wulf-Dieter |
author_sort | Hartinger, Doris |
collection | PubMed |
description | BACKGROUND: Fumonisin B(1 )is a cancerogenic mycotoxin produced by Fusarium verticillioides and other fungi. Sphingopyxis sp. MTA144 can degrade fumonisin B(1), and a key enzyme in the catabolic pathway is an aminotransferase which removes the C2-amino group from hydrolyzed fumonisin B(1). In order to study this aminotransferase with respect to a possible future application in enzymatic fumonisin detoxification, we attempted expression of the corresponding fumI gene in E. coli and purification of the enzyme. Since the aminotransferase initially accumulated in inclusion bodies, we compared the effects of induction level, host strain, expression temperature, solubility enhancers and a fusion partner on enzyme solubility and activity. RESULTS: When expressed from a T7 promoter at 30°C, the aminotransferase accumulated invariably in inclusion bodies in DE3 lysogens of the E. coli strains BL21, HMS174, Rosetta 2, Origami 2, or Rosetta-gami. Omission of the isopropyl-beta-D-thiogalactopyranoside (IPTG) used for induction caused a reduction of expression level, but no enhancement of solubility. Likewise, protein production but not solubility correlated with the IPTG concentration in E. coli Tuner(DE3). Addition of the solubility enhancers betaine and sorbitol or the co-enzyme pyridoxal phosphate showed no effect. Maltose-binding protein, used as an N-terminal fusion partner, promoted solubility at 30°C or less, but not at 37°C. Low enzyme activity and subsequent aggregation in the course of purification and cleavage indicated that the soluble fusion protein contained incorrectly folded aminotransferase. Expression in E. coli ArcticExpress(DE3), which co-expresses two cold-adapted chaperonins, at 11°C finally resulted in production of appreciable amounts of active enzyme. Since His tag-mediated affinity purification from this strain was hindered by co-elution of chaperonin, two steps of chromatography with optimized imidazole concentration in the binding buffer were performed to obtain 1.45 mg of apparently homogeneous aminotransferase per liter of expression culture. CONCLUSIONS: We found that only reduction of temperature, but not reduction of expression level or fusion to maltose-binding protein helped to produce correctly folded, active aminotransferase FumI in E. coli. Our results may provide a starting point for soluble expression of related aminotransferases or other aggregation-prone proteins in E. coli. |
format | Text |
id | pubmed-2933618 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29336182010-09-07 Enhancement of solubility in Escherichia coli and purification of an aminotransferase from Sphingopyxis sp. MTA144 for deamination of hydrolyzed fumonisin B(1) Hartinger, Doris Heinl, Stefan Schwartz, Heidi Elisabeth Grabherr, Reingard Schatzmayr, Gerd Haltrich, Dietmar Moll, Wulf-Dieter Microb Cell Fact Research BACKGROUND: Fumonisin B(1 )is a cancerogenic mycotoxin produced by Fusarium verticillioides and other fungi. Sphingopyxis sp. MTA144 can degrade fumonisin B(1), and a key enzyme in the catabolic pathway is an aminotransferase which removes the C2-amino group from hydrolyzed fumonisin B(1). In order to study this aminotransferase with respect to a possible future application in enzymatic fumonisin detoxification, we attempted expression of the corresponding fumI gene in E. coli and purification of the enzyme. Since the aminotransferase initially accumulated in inclusion bodies, we compared the effects of induction level, host strain, expression temperature, solubility enhancers and a fusion partner on enzyme solubility and activity. RESULTS: When expressed from a T7 promoter at 30°C, the aminotransferase accumulated invariably in inclusion bodies in DE3 lysogens of the E. coli strains BL21, HMS174, Rosetta 2, Origami 2, or Rosetta-gami. Omission of the isopropyl-beta-D-thiogalactopyranoside (IPTG) used for induction caused a reduction of expression level, but no enhancement of solubility. Likewise, protein production but not solubility correlated with the IPTG concentration in E. coli Tuner(DE3). Addition of the solubility enhancers betaine and sorbitol or the co-enzyme pyridoxal phosphate showed no effect. Maltose-binding protein, used as an N-terminal fusion partner, promoted solubility at 30°C or less, but not at 37°C. Low enzyme activity and subsequent aggregation in the course of purification and cleavage indicated that the soluble fusion protein contained incorrectly folded aminotransferase. Expression in E. coli ArcticExpress(DE3), which co-expresses two cold-adapted chaperonins, at 11°C finally resulted in production of appreciable amounts of active enzyme. Since His tag-mediated affinity purification from this strain was hindered by co-elution of chaperonin, two steps of chromatography with optimized imidazole concentration in the binding buffer were performed to obtain 1.45 mg of apparently homogeneous aminotransferase per liter of expression culture. CONCLUSIONS: We found that only reduction of temperature, but not reduction of expression level or fusion to maltose-binding protein helped to produce correctly folded, active aminotransferase FumI in E. coli. Our results may provide a starting point for soluble expression of related aminotransferases or other aggregation-prone proteins in E. coli. BioMed Central 2010-08-18 /pmc/articles/PMC2933618/ /pubmed/20718948 http://dx.doi.org/10.1186/1475-2859-9-62 Text en Copyright ©2010 Hartinger et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Hartinger, Doris Heinl, Stefan Schwartz, Heidi Elisabeth Grabherr, Reingard Schatzmayr, Gerd Haltrich, Dietmar Moll, Wulf-Dieter Enhancement of solubility in Escherichia coli and purification of an aminotransferase from Sphingopyxis sp. MTA144 for deamination of hydrolyzed fumonisin B(1) |
title | Enhancement of solubility in Escherichia coli and purification of an aminotransferase from Sphingopyxis sp. MTA144 for deamination of hydrolyzed fumonisin B(1) |
title_full | Enhancement of solubility in Escherichia coli and purification of an aminotransferase from Sphingopyxis sp. MTA144 for deamination of hydrolyzed fumonisin B(1) |
title_fullStr | Enhancement of solubility in Escherichia coli and purification of an aminotransferase from Sphingopyxis sp. MTA144 for deamination of hydrolyzed fumonisin B(1) |
title_full_unstemmed | Enhancement of solubility in Escherichia coli and purification of an aminotransferase from Sphingopyxis sp. MTA144 for deamination of hydrolyzed fumonisin B(1) |
title_short | Enhancement of solubility in Escherichia coli and purification of an aminotransferase from Sphingopyxis sp. MTA144 for deamination of hydrolyzed fumonisin B(1) |
title_sort | enhancement of solubility in escherichia coli and purification of an aminotransferase from sphingopyxis sp. mta144 for deamination of hydrolyzed fumonisin b(1) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933618/ https://www.ncbi.nlm.nih.gov/pubmed/20718948 http://dx.doi.org/10.1186/1475-2859-9-62 |
work_keys_str_mv | AT hartingerdoris enhancementofsolubilityinescherichiacoliandpurificationofanaminotransferasefromsphingopyxisspmta144fordeaminationofhydrolyzedfumonisinb1 AT heinlstefan enhancementofsolubilityinescherichiacoliandpurificationofanaminotransferasefromsphingopyxisspmta144fordeaminationofhydrolyzedfumonisinb1 AT schwartzheidielisabeth enhancementofsolubilityinescherichiacoliandpurificationofanaminotransferasefromsphingopyxisspmta144fordeaminationofhydrolyzedfumonisinb1 AT grabherrreingard enhancementofsolubilityinescherichiacoliandpurificationofanaminotransferasefromsphingopyxisspmta144fordeaminationofhydrolyzedfumonisinb1 AT schatzmayrgerd enhancementofsolubilityinescherichiacoliandpurificationofanaminotransferasefromsphingopyxisspmta144fordeaminationofhydrolyzedfumonisinb1 AT haltrichdietmar enhancementofsolubilityinescherichiacoliandpurificationofanaminotransferasefromsphingopyxisspmta144fordeaminationofhydrolyzedfumonisinb1 AT mollwulfdieter enhancementofsolubilityinescherichiacoliandpurificationofanaminotransferasefromsphingopyxisspmta144fordeaminationofhydrolyzedfumonisinb1 |